Sign in
4

Changes in Ownership

AEON Biopharma, Inc. Filed Acc 0001104659-23-083568

Options or other derivatives

  • Director acquired 20,809 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Carter Eric G · Director

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2023-07-21 Grant or award : show line 1 in the form Stock Option +9,007 9,007 D
2023-07-21 Grant or award : show line 2 in the form Stock Option +11,802 11,802 D
Loading xslF345X05/tm2321918-11_4seq1.xml…